Fairness analysis analysts forecast Acutus Medical, Inc. (NASDAQ: AFIB) to submit earnings per share (EPS) of ($ 0.71) for the present fiscal quarter, Zacks experiences. Two analysts supplied earnings estimates for Acutus Medical. The decrease estimate of EPS is ($ 0.84) and the upper is ($ 0.53). The corporate is anticipated to launch its subsequent quarterly outcomes on Thursday, March 4.
On common, analysts count on Acutus Medical to report annual earnings of ($ 60.79) per share for the present fiscal 12 months. For the subsequent fiscal 12 months, analysts predict the corporate will submit earnings of ($ 2.98) per share, with EPS estimates starting from ($ 3.12) to ($ 2.81). Zacks’ earnings per share calculations are a median primarily based on a survey of analysts who comply with Acutus Medical.
A number of fairness analysts not too long ago commented on AFIB shares. Canaccord Genuity reaffirmed a “maintain” ranking and set a goal worth of $ 30.00 on Acutus Medical shares in a report on Thursday, January 14. Zacks funding analysis upgraded Acutus Medical’s shares from a “promote” ranking to a “preserve” ranking in a report launched on Tuesday, January 19. Lastly, Financial institution of America downgraded Acutus Medical’s inventory from a “purchase” ranking to a “impartial” ranking and lowered its share worth goal from $ 38.00 to $ 30.00 in a analysis report on Thursday, January 14. Three fairness analysis analysts rated the inventory with a sustaining ranking and three gave the corporate’s inventory a purchase ranking. Acutus Medical at present has a consensus ranking of “Purchase” and a median worth goal of $ 34.75.
Quite a lot of institutional buyers and hedge funds have not too long ago purchased and offered shares within the firm. Roubaix Capital LLC acquired a brand new stake in Acutus Medical through the third quarter valued at roughly $ 1,275,000. American Worldwide Group Inc. acquired a brand new fairness curiosity in Acutus Medical through the third quarter valued at roughly $ 175,000. Wells Fargo & Firm MN acquired a brand new place in Acutus Medical within the third quarter valued at roughly $ 11,030,000. Index Enterprise Associates V Ltd acquired a brand new place in shares of Acutus Medical through the third quarter valued at roughly $ 4,875,000. Lastly, the California Public Workers Retirement System bought a brand new stake in Acutus Medical shares through the third quarter valued at roughly $ 630,000. Institutional buyers and hedge funds maintain 69.56% of the corporate’s shares.
NASDAQ: AFIB open for $ 20.76 on Mondays. The 50-day shifting common share worth is $ 25.74. Acutus Medical has a 52 week minimal of $ 19.78 and a 52 week most of $ 38.99. The corporate has a present ratio of 10.89, a fast ratio of 10.21, and a debt ratio of 0.25.
About Acutus Medical
Acutus Medical, Inc., an arrhythmia administration firm, designs, manufactures and markets a line of instruments for catheter ablation procedures to deal with varied arrhythmias in the USA and world wide. It provides an AcQMap console and workstation, a complicated imaging, navigation and mapping system that enables physicians to map, deal with, crop and alter extra remedy as wanted; and the affected person electrode equipment required in every process to supply cardiac indicators, catheter location, and grounding of the AcQMap system.
Study extra: Intrinsic worth
For extra info on Zacks Funding Analysis’s analysis choices, go to Zacks.com
This immediate information alert was powered by storytelling know-how and monetary knowledge from MarketBeat to supply readers with the quickest, most correct experiences. This story was reviewed by the MarketBeat editorial staff previous to publication. Please ship any questions or feedback about this story to [email protected]